Close X
Saturday, September 21, 2024
ADVT 
International

Indian national dies after being hit by bus in Australia

Darpan News Desk IANS, 24 Jul, 2023 11:11 AM
  • Indian national dies after being hit by bus in Australia

Melbourne, July 24 (IANS) A 28-year-old Indian national from Ludhiana, who had been working as a driver for the past six months in South Australia, died after being hit by a bus.

Gagandeep Singh from Ludhiana had parked his bus on Conroy Street and had exited when the bus rolled forward and pinned him against a gate this month, Australian broadcaster SBS Punjabi reported.

While Gagandeep received immediate medical response from paramedics at the scene, he died after being transported to a nearby hospital, police said.

“I talked to him (the) day before the incident. Excitedly sharing his plans for the future, he mentioned that it would be his final shift as a bus driver in Port Augusta. He had been eagerly looking forward to relocating to Melbourne later this month. Little did he know that fate had other plans in store for him,” Rubal Singh, a relative of the deceased, told SBS Punjabi.

Rubal Singh said that the Major Crash Unit was investigating the circumstances leading to his death.

“We believe somehow the handbrake wasn’t applied to the bus that he parked at the yard. After exiting the bus, he realised that it was still moving. He tried to stop it by shutting down the roller gate but was tragically crushed between the bus and the gate,” he added.

A fundraiser has been set up by the community to take Gagandeep's body back to India and support the family that lost their only son and working member.

“Tragedy has struck the family as we mourn the sudden and untimely loss of our beloved, Gagandeep Singh,” GoFundMe organiser Sunny Singh wrote.

“Together, we want to honour Gagandeep’s memory and send him back to his parents in India so they can say their final goodbyes following all the last rituals and traditions.”

The campaign has so far raised A$59,000.

MORE International ARTICLES

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

China permits Indian students to return on 'need-assessed' basis

China permits Indian students to return on 'need-assessed' basis
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.

China permits Indian students to return on 'need-assessed' basis